Active Pharmaceutical Ingredient (API)
Belinostat
HDAC Inhibitor
A histone deacetylase inhibitor used to treat Peripheral T-cell Lymphoma ($\text{PTCL}$). It induces cell cycle arrest and apoptosis in transformed cells.
Technical Profile
- Reference Code
- BEL711
- CAS Number
- 414864-00-9
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Belinostat as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||